Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells

Background: The mitotic kinesin, KIF18A, is required for proliferation of cancer cells that exhibit chromosome instability (CIN), implicating it as a promising target for treatment of a subset of aggressive tumor types. Determining regions of the KIF18A protein to target for inhibition will be impor...

Full description

Bibliographic Details
Main Authors: Katherine L. Schutt, Katelyn A. Queen, Kira Fisher, Olivia Budington, Weifeng Mao, Wei Liu, Xiaohui Gu, Yisong Xiao, Fred Aswad, James Joseph, Jason Stumpff
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2024.1328077/full
_version_ 1827352984910036992
author Katherine L. Schutt
Katelyn A. Queen
Kira Fisher
Olivia Budington
Weifeng Mao
Wei Liu
Xiaohui Gu
Yisong Xiao
Fred Aswad
James Joseph
Jason Stumpff
author_facet Katherine L. Schutt
Katelyn A. Queen
Kira Fisher
Olivia Budington
Weifeng Mao
Wei Liu
Xiaohui Gu
Yisong Xiao
Fred Aswad
James Joseph
Jason Stumpff
author_sort Katherine L. Schutt
collection DOAJ
description Background: The mitotic kinesin, KIF18A, is required for proliferation of cancer cells that exhibit chromosome instability (CIN), implicating it as a promising target for treatment of a subset of aggressive tumor types. Determining regions of the KIF18A protein to target for inhibition will be important for the design and optimization of effective small molecule inhibitors.Methods: In this study, we used cultured cell models to investigate the effects of mutating S284 within the alpha-4 helix of KIF18A, which was previously identified as a phosphorylated residue.Results: Mutations in S284 cause relocalization of KIF18A from the plus-ends of spindle microtubules to the spindle poles. Furthermore, KIF18A S284 mutants display loss of KIF18A function and fail to support proliferation in CIN tumor cells. Interestingly, similar effects on KIF18A localization and function were seen after treatment of CIN cells with KIF18A inhibitory compounds that are predicted to interact with residues within the alpha-4 helix.Conclusion: These data implicate the KIF18A alpha-4 helix as an effective target for inhibition and demonstrate that small molecules targeting KIF18A selectively limit CIN tumor cell proliferation and result in phenotypically similar effects on mitosis at the single cell level compared to genetic perturbations.
first_indexed 2024-03-08T03:17:00Z
format Article
id doaj.art-cc433fd5932f40ad91df8b3c7b187486
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-03-08T03:17:00Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-cc433fd5932f40ad91df8b3c7b1874862024-02-12T15:38:46ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2024-02-011110.3389/fmolb.2024.13280771328077Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cellsKatherine L. Schutt0Katelyn A. Queen1Kira Fisher2Olivia Budington3Weifeng Mao4Wei Liu5Xiaohui Gu6Yisong Xiao7Fred Aswad8James Joseph9Jason Stumpff10Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT, United StatesDepartment of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT, United StatesDepartment of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT, United StatesDepartment of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT, United StatesApeiron Therapeutics, Shanghai, ChinaApeiron Therapeutics, Shanghai, ChinaApeiron Therapeutics, Shanghai, ChinaApeiron Therapeutics, Shanghai, ChinaApeiron Therapeutics, Burlingame, CA, United StatesApeiron Therapeutics, Burlingame, CA, United StatesDepartment of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT, United StatesBackground: The mitotic kinesin, KIF18A, is required for proliferation of cancer cells that exhibit chromosome instability (CIN), implicating it as a promising target for treatment of a subset of aggressive tumor types. Determining regions of the KIF18A protein to target for inhibition will be important for the design and optimization of effective small molecule inhibitors.Methods: In this study, we used cultured cell models to investigate the effects of mutating S284 within the alpha-4 helix of KIF18A, which was previously identified as a phosphorylated residue.Results: Mutations in S284 cause relocalization of KIF18A from the plus-ends of spindle microtubules to the spindle poles. Furthermore, KIF18A S284 mutants display loss of KIF18A function and fail to support proliferation in CIN tumor cells. Interestingly, similar effects on KIF18A localization and function were seen after treatment of CIN cells with KIF18A inhibitory compounds that are predicted to interact with residues within the alpha-4 helix.Conclusion: These data implicate the KIF18A alpha-4 helix as an effective target for inhibition and demonstrate that small molecules targeting KIF18A selectively limit CIN tumor cell proliferation and result in phenotypically similar effects on mitosis at the single cell level compared to genetic perturbations.https://www.frontiersin.org/articles/10.3389/fmolb.2024.1328077/fullmitosiskinesinspindleKIF18Achromosome instabilitysmall-molecule inhibitor
spellingShingle Katherine L. Schutt
Katelyn A. Queen
Kira Fisher
Olivia Budington
Weifeng Mao
Wei Liu
Xiaohui Gu
Yisong Xiao
Fred Aswad
James Joseph
Jason Stumpff
Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells
Frontiers in Molecular Biosciences
mitosis
kinesin
spindle
KIF18A
chromosome instability
small-molecule inhibitor
title Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells
title_full Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells
title_fullStr Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells
title_full_unstemmed Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells
title_short Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells
title_sort identification of the kif18a alpha 4 helix as a therapeutic target for chromosomally unstable tumor cells
topic mitosis
kinesin
spindle
KIF18A
chromosome instability
small-molecule inhibitor
url https://www.frontiersin.org/articles/10.3389/fmolb.2024.1328077/full
work_keys_str_mv AT katherinelschutt identificationofthekif18aalpha4helixasatherapeutictargetforchromosomallyunstabletumorcells
AT katelynaqueen identificationofthekif18aalpha4helixasatherapeutictargetforchromosomallyunstabletumorcells
AT kirafisher identificationofthekif18aalpha4helixasatherapeutictargetforchromosomallyunstabletumorcells
AT oliviabudington identificationofthekif18aalpha4helixasatherapeutictargetforchromosomallyunstabletumorcells
AT weifengmao identificationofthekif18aalpha4helixasatherapeutictargetforchromosomallyunstabletumorcells
AT weiliu identificationofthekif18aalpha4helixasatherapeutictargetforchromosomallyunstabletumorcells
AT xiaohuigu identificationofthekif18aalpha4helixasatherapeutictargetforchromosomallyunstabletumorcells
AT yisongxiao identificationofthekif18aalpha4helixasatherapeutictargetforchromosomallyunstabletumorcells
AT fredaswad identificationofthekif18aalpha4helixasatherapeutictargetforchromosomallyunstabletumorcells
AT jamesjoseph identificationofthekif18aalpha4helixasatherapeutictargetforchromosomallyunstabletumorcells
AT jasonstumpff identificationofthekif18aalpha4helixasatherapeutictargetforchromosomallyunstabletumorcells